Clinical Trial Update: Single Arm Study With a Nitinol Self-Expanding Paclitaxel-Eluting Stent to Treat BTK Arteries [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 single-arm trial evaluated a nitinol self-expanding paclitaxel-eluting stent for treating below-the-knee peripheral arterial disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• paclitaxel-eluting nitinol self-expanding stent (paclitaxel-eluting nitinol self-expanding stent)

Snippet

Sponsor: Flanders Medical Research Program | Conditions: Peripheral Arterial Disease | Phase 2, Phase 3 | Status: COMPLETED